• Home >>
• Patient Testimonials >>
• Rwandan Patient Successfully Treats Leukemia with CAR-T Cell Therapy in India

Rwandan Patient Successfully Treats Leukemia with CAR-T Cell Therapy in India

Patient Name: Mr.Vincent Mbanza
Age: 22
Gender: Male
Country of Origin: Rwanda
Treatment: CAR-T Cell Therapy for Leukemia
Patient Rating: ★★★★★ 4.9/5

Leukemia is a cancerous cells crowd out healthy blood cells, leading to symptoms such as persistent fatigue, frequent infections, unexplained weight loss, easy bruising or bleeding, fever and night sweats. At first, he thought he was just tired from college. But then he started getting bruises easily, my gums would bleed, and he was constantly exhausted. Alarmed by the persistence of these symptoms, Vincent visited a local clinic in Rwanda. After a series of blood tests and bone marrow evaluations, the diagnosis came — Acute Lymphoblastic Leukemia (ALL).

In Rwanda, while basic treatments were available, Vincent and his family quickly realized that the cutting-edge therapies needed to battle his aggressive form of leukemia were not accessible. Determined to find the best possible care, he turned to the internet to explore treatment options abroad. His online search introduced him to CAR-T Cell Therapy, a revolutionary treatment for certain types of leukemia. He also discovered that India had some of the most advanced CAR-T therapy programs in the world, combined with world-class doctors and affordable care for international patients. And that’s when he found us—a trusted name in medical tourism facilitation.

Vincent reached out to us with many questions, curious but cautious. We took the time to understand his case in detail and connected him with one of the top hemato oncologists in India who specialized in CAR-T Cell Therapy. After reviewing Vincent’s medical history, lab reports, and current condition, the specialist confirmed that he was indeed a good candidate for CAR-T Cell Therapy. The urgency of his condition required that he fly to India as soon as possible, and we arranged everything for him flight and visa assistance, airport pickup and drop-off, hotel accommodation near the hospital, scheduled consultations with the doctor, language interpretation and 24/7 support.

CAR-T Cell therapy (Chimeric Antigen Receptor T-cell Therapy) is a type of immunotherapy where a patient’s T-cells (a kind of white blood cell) are collected and genetically modified in a lab to recognize and attack cancer cells. The steps generally include:

• T-Cell Collection – Blood is drawn from the patient, and the T-cells are isolated.
• Modification – The T-cells are engineered to express CARs that target cancer cells.
• Multiplication – These modified T-cells are multiplied in a lab.

Infusion – After a short chemotherapy regimen, the CAR-T cells are infused back into the patient to find and destroy cancer cells.

Vincent was fascinated by the science behind this treatment and felt hopeful knowing that his own immune system would now be re-engineered to fight the cancer.

Upon landing in India, Vincent was received at the airport by our local consultant and transported to his pre-booked accommodation. The very next day, he was taken to the hospital, where his consultation with the best hemato oncologist in India had already been scheduled. The doctor took time to explain every step of the therapy to Vincent and his accompanying family member. After thorough pre-treatment evaluations, including advanced imaging, genetic profiling, immunology tests, psychological assessment.

The CAR-T therapy began with T-cell collection, which was sent to a specialized lab for modification. During the waiting period, Vincent received bridging chemotherapy to keep his leukemia under control. When the lab-modified T-cells were ready (usually within 2–3 weeks), Vincent was hospitalized for the cell infusion. Though the actual infusion process was brief, the days following it were critical, as doctors closely monitored him for any side effects such as fever, cytokine release syndrome (crs), neurological symptoms. Thanks to proactive care and a skilled medical team, Vincent experienced only mild side effects, which were managed efficiently. After a few days in the hospital, he was stable and cleared for outpatient monitoring.

Vincent remained under observation for several weeks after his infusion. During this time, regular blood tests and scans showed tremendous improvement. His leukemia markers had dropped drastically, and healthy blood cell counts began to normalize. He was prescribed medication for immune support and underwent lifestyle counseling to help him regain his strength. With every passing week, Vincent felt better—stronger, more energetic, and hopeful. He could literally feel his body fighting back. I woke up one day and didn’t feel tired or sick. It was magical.

With the doctor’s approval and complete post-treatment documentation in hand, Vincent flew back to Rwanda —a changed man. Not only was he physically healthier, but mentally and emotionally revitalized. Before his departure, he thanked every member of our team who stood by his side The consultant who received him, the interpreter who helped him communicate, the logistics team who arranged every appointment, the doctors and nurses who cared for him like family. For patients like Vincent, who come from countries with limited access to cutting-edge oncology treatments, India offers hope, healing, and high success rates.

Vincent Mbanza's story is not just a tale of beating cancer—it’s a powerful reminder of what happens when courage meets opportunity. His choice to seek CAR-T Cell Therapy in India transformed his life, giving him a new beginning and a renewed passion for the future. He now encourages other young people in Rwanda and beyond not to lose hope, even in the face of a cancer diagnosis. “Trust the process, and trust the science. If you want to live, fight for it. I did—and I’m here, stronger than ever,” Vincent says.

Thank You
Vincent Mbanza
Rwanda

---